Metformin's Anti-Aging Case: Strong Clues but Still No Proof
Moderate Evidence·Molecular and cellular endocrinology·Apr 2026
This review pulls together lab, population, and clinical trial evidence on metformin as a potential aging-slowing drug. At normal doses, metformin seems to flip several key aging switches: boosting cellular cleanup, calming inflammation, and improving energy production. Large population studies link metformin use to lower rates of age-related diseases, even in people without diabetes. However, the review honestly notes that metformin may actually worsen aging in older animals, so the picture is still mixed.
Key Insight
This review suggests metformin shows promise against aging but its effects may differ by age.
Original Paper
Molecular and cellular endocrinology
